(HealthDay News) — A company has agreed to pay $60 million to settle charges by US state attorneys general that it failed to adequately inform women of dangerous side effects associated with permanent pelvic mesh devices.

The payment by CR Bard Inc. and its parent company Becton, Dickinson and Co. will be shared by 48 states and the District of Columbia, CBS News reported.

“Bard failed to disclose serious and life-altering risks of permanently implanted surgical mesh devices, leaving thousands of women to suffer,” Mississippi Attorney General Lynn Fitch said in a statement. “This settlement holds Bard accountable for its deceptive business practices.”

CR Bard and its parent company have denied any allegations of wrongdoing, and chose to settle the matter “to avoid the time and expense of further litigation,” according to Troy Kirkpatrick, a spokesperson for Becton, Dickinson and Co., CBS News reported.

Continue Reading


Company to pay $60 million for deceptive marketing with pelvic mesh. CBS News; September 25, 2020.